Global STD Diagnostics Market Size (2024 - 2029)

STD Diagnostics Market Analysis

The Global STD Diagnostics Market size is estimated at USD 16.98 billion in 2024, and is expected to reach USD 23.91 billion by 2029, growing at a CAGR of 7.08% during the forecast period (2024-2029).

Sexually transmitted diseases (STDs) are spread mainly by sexual contact. Sexually transmitted diseases (STIs) are caused by bacteria, viruses, or parasites. These STIs-causing microorganisms can be diagnosed by using STD diagnostics and help in receiving proper treatment. Factors such as the growing prevalence of STDs globally, growing government initiatives to create awareness about STDs, and increasing advancement in STD diagnostics are anticipated to drive the STD diagnostics market during the forecast period. The rising prevalence of STDs is expected to drive the market during the forecast period. For instance, the World Health Organization Report 2023 reported that more than 1.0 million sexually transmitted infections are acquired globally, and most of them are asymptomatic. It also reported that every year, there are an estimated 374.0 million new infections, with 1 out of 4 sexually transmitted infections: gonorrhea, chlamydia, trichomoniasis, and syphilis. Therefore, such an increasing prevalence and incidence rate of sexually transmitted diseases around the globe is expected to increase the demand for STD diagnostics, thereby propelling market growth during the forecast period. Also, the increasing government organizations' initiatives to create awareness about STDs are expected to increase the demand for STD diagnostics procedures for early detection of infections. For instance, in March 2022, the National Chlamydia Screening Program (NCSP) was organized in the United Kingdom. The major focus of this program was to reduce the harm of untreated chlamydia infection by primarily screening women and girls. In June 2022, the Centers for Disease Control and Prevention (CDC) recommended and issued guidelines for screening sexually transmitted diseases to create awareness toward screening programs for STDs and the increasing burden of STDs around the globe. Hence, such initiatives by government organizations are expected to drive the demand for the diagnosis of STDs, which is expected to drive the market during the forecast period. Also, advancements in STD diagnostics, research, and the development of new technologies are projected to fuel market growth. Also, the market is witnessing a major shift from conventional technologies to molecular diagnostics for the diagnosis of STDs, which is a breakthrough for the growth of the market. For instance, in May 2022, Medmira Inc. received a CE mark for its Multiplo complete syphilis (TP/nTP) antibody test (Multiplo TP/nTP). This approval enables the company to strengthen further its product offering in all markets that accept the CE mark. Hence, the rising prevalence of STDs, increasing government organizations' initiatives to increase awareness about STDs, and increasing product launches are expected to drive the STD diagnostic market. However, the social stigma associated with patients visiting specialized STD clinics and stringent regulatory scenarios for product approvals is expected to restrain the market during the forecast period.

STD Diagnostics Industry Segmentation

As per the scope of the report, STDs are infections that transmit from one person to another during oral, anal, and vaginal sex. Bacteria, parasites, yeast, and viruses are the main causes of STDs. Rapid and early diagnosis of STDs will limit the effects and progression of the disease. If the STDs are left untreated, they can lead to more serious and long-term health complications. The STD diagnostics market is segmented by type of disease, location of diagnostic test, device, and geography. By type, the market is segmented into chlamydia, gonorrhea, syphilis, genital herpes, hepatitis B, HIV/AIDS (human immunodeficiency virus and acquired immune deficiency syndrome), human papillomavirus, and other diseases. By devices, the market is segmented into laboratory devices (thermal cyclers - PCR, lateral flow readers immunochromatographic assays, flow cytometers, absorbance microplate reader - enzyme-linked immunosorbent assay (ELISA), and other laboratory devices) and point-of-care devices, phone chips (microfluidics + ICT), and portable/benchtop/rapid diagnostic kits). By geography, the market is segmented into North America, Europe, Asia-Pacific, the Middle East and Africa, and South America. The report also covers the estimated market sizes and trends for 17 countries across significant global regions. The report offers the value (in USD) for the above segments.